Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 88

Sort by

Sort Order Select

Journal Articles

All-trans retinoic acid for refractory cancer therapy-induced thrombocytopenia: A new option beyond TPO-ras?

Linya Wang, Haitao Gao, Qiang Fu, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Feifei Tang

Blood (2025) 146 (Supplement 1): 1265.

https://doi.org/10.1182/blood-2025-1265

Published: 2025

Journal Articles

Iguratimod plus low-dose rituximab as second-line treatment in adults with primary immune thrombocytopenia: A multicenter, open-label, randomized, controlled, Phase 2 trial

Qiu-Sha Huang, Zhuo-Yu An, Peng Zhao, Qi Chen, Jin Wu, Hai-Xia Fu, Yujun Dong, Hongmei Jing, Liping Dou, Hui Liu, Yi Liu, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3044.

https://doi.org/10.1182/blood-2025-3044

Published: 2025

Journal Articles

Clinical features and prognostic model for adenovirus infection following allogeneic hematopoietic stem cell transplantation: Insights from a Chinese cohort

Jiaxin Zhang, Jin Wu, Hai-Xia Fu, Yuanyuan Zhang, Xiao-Dong Mo, Feng-Rong Wang, Yuqian Sun, Meng Lv, Yuhong Chen, Xiang-Yu Zhao, Yu Wang, Ying-Jun Chang, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 6056.

https://doi.org/10.1182/blood-2025-6056

Published: 2025

Journal Articles

The selective JAK1 inhibitor upadacitinib restores impaired neutrophil chemotaxis in the proplatelet formation of immune thrombocytopenia

Qiu-Sha Huang, Qing-Yuan Qu, Zhuo-Yu An, Peng Zhao, Qi Chen, Jin Wu, Hai-Xia Fu, Ying-Jun Chang, Xiang-Yu Zhao, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 197.

https://doi.org/10.1182/blood-2025-197

Published: 2025

Journal Articles

A novel thiotepa-containing conditioning regimen for haploidentical hematopoietic cell transplantation in pediatric aplastic anemia at high risk of cardiotoxicity

Feng Zhang, Suo Pan, Guanhua Hu, Lu Bai, Yingxi Zuo, Zhengli Xu, Lanping Xu, Yu Wang, Xiaohui Zhang, Xiaojun Huang, Yifei CHENG

Blood (2025) 146 (Supplement 1): 5977.

https://doi.org/10.1182/blood-2025-5977

Published: 2025

Journal Articles

Fus::ERG fusion represents adverse-plus risk group in AML patients: Evidence from a registry-based matched cohort Study

Yi-Han Yang, Meng Lv, Jia Chen, Jing Liu, Xiaohui Zhang, Lanping Xu, Xi Zhang, Daihong Liu, Depei Wu, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 1706.

https://doi.org/10.1182/blood-2025-1706

Published: 2025

Journal Articles

A novel Janus kinase 1 and 2 inhibitor, baricitinib, for steroid-refractory chronic graft-versus-host disease after allogeneic stem cell transplantation

Chen Zhao, Yuanyuan Zhang, Hai-Xia Fu, Xiao-Dong Mo, Zhi-Dong Wang, Fengrong Wang, Yuhong Chen, Yuqian Sun, Yu Wang, Ying-Jun Chang, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 6015.

https://doi.org/10.1182/blood-2025-6015

Published: 2025

Journal Articles

IDH1/2 mutations predict a distinct high-risk subset in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia

Lijuan Hu, Sheng-Ye Lu, Lu Yu, Zongru Li, Hao Jiang, Xiaohui Zhang, Lanping Xu, Yu Wang, Qian Jiang, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 3374.

https://doi.org/10.1182/blood-2025-3374

Published: 2025

Journal Articles

Beyond the unknown: Leveraging machine learning to predict adverse outcomes in pregnant women with aplastic anemia from a representative nationwide cohort

Blood (2025) 146 (Supplement 1): 1413.

https://doi.org/10.1182/blood-2025-1413

Published: 2025

Journal Articles

Bzip in-frame mutations might abrogate the adverse prognosis of therapy-related CEBPA-mutated AML

Guanghui Chang, Haitao Gao, Qiang Fu, Xiaosu Zhao, Yu Wang, Qian Jiang, Hao Jiang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Feifei Tang

Blood (2025) 146 (Supplement 1): 5163.

https://doi.org/10.1182/blood-2025-5163

Published: 2025

Journal Articles

Selecting the optimal bridging therapy for B-ALL: A multicenter comparison of blinatumomab, inotuzumab ozogamicin, and CAR-T prior to allo-HSCT

Ao-Ran Zhang, Guanhua Hu, Xianying Yin, Sheng-Ye Lu, Xiao-Dong Mo, Yuqian Sun, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiangyu Zhao, Xiaojun Huang, Yi-Fei Cheng, Meng Lv

Blood (2025) 146 (Supplement 1): 4298.

https://doi.org/10.1182/blood-2025-4298

Published: 2025

Journal Articles

Low dose of IL-2 application for graft-versus-host disease prophylaxis following haploidentical stem cell transplantation

Xiangyu Zhao, Zhengli Xu, Meng Lv, Xingxing Yu, Yiyang Ding, Ting-ting Han, Hai-Xia Fu, Yuanyuan Zhang, Xiao-Dong Mo, Yuqian Sun, Lanping Xu, Xiaohui Zhang, Yu Wang, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 7774.

https://doi.org/10.1182/blood-2025-7774

Published: 2025

Journal Articles

Ectopic EBV infection in T cells following allogeneic hematopoietic stem cell transplantation: Clinical outcomes and immunological characterization

Zhifan Zhao, Lanping Xu, Xiangyu Zhao, Yu Wang, Xiaohui Zhang, Xiaojun Huang, Xuying Pei

Blood (2025) 146 (Supplement 1): 2449.

https://doi.org/10.1182/blood-2025-2449

Published: 2025

Journal Articles

Single-cell dissection of pathogenic T-cell response to tacrolimus in immune thrombocytopenia

Li-Ping Yang, Peng Zhao, Qiu-Sha Huang, Xiang-Yu Zhao, Qian Jiang, Ying-Jun Chang, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3024.

https://doi.org/10.1182/blood-2025-3024

Published: 2025

Journal Articles

Avatrombopag improves platelet engraftment after haploidentical hematopoietic stem cell transplantation: A randomized, double-blind, multicenter, placebo-controlled trial

Blood (2025) 146 (Supplement 1): 377.

https://doi.org/10.1182/blood-2025-377

Published: 2025

Journal Articles

Co-mutation of BCOR and BCORL1 was associated with favorable outcome in the adverse risk patients with Acute Myeloid Leukemia

Shunjie Yu, Zongru Li, Lijuan Hu, Ya-Zhen Qin, Guorui Ruan, Yazhe Wang, Hao Jiang, Feifei Tang, Jinsong JIA, Jing Wang, Qiang Fu, Xiaohui Zhang, Lanping Xu, Yu Wang, Yuqian Sun, Yueyun Lai, Hong-Xia Shi, Xiaojun Huang, Qian Jiang

Blood (2025) 146 (Supplement 1): 3400.

https://doi.org/10.1182/blood-2025-3400

Published: 2025

Journal Articles

Outcomes and risk factors of second allogeneic hematopoietic stem cell transplantation in patients with relapsed hematological malignancy after first transplantation

Xiaolu Zhu, Hai-Xia Fu, Jing Liu, Zhengli Xu, Yuqian Sun, Meng Lv, Xiao-Dong Mo, Yi-Fei Cheng, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Yu Wang

Blood (2025) 146 (Supplement 1): 6047.

https://doi.org/10.1182/blood-2025-6047

Published: 2025

Journal Articles

Droplet digital PCR improves measurable residual disease detection and predicts relapse in KMT2A-rearranged leukemia after allogeneic hematopoietic stem cell transplantation: A prospective study

Ya Luo, Ya-Zhen Qin, Xiaosu Zhao, Ying-Jun Chang, Jing Liu, Xiao-Dong Mo, Yuqian Sun, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Meng Lv

Blood (2025) 146 (Supplement 1): 3518.

https://doi.org/10.1182/blood-2025-3518

Published: 2025

Journal Articles

Impact of HLA-b leader matching status on prognosis and underlying mechanism in patients with hematological malignancies following haploidentical hematopoietic stem cell transplantation

Minghao Lin, Yuanyuan Zhang, Zhengli Xu, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Xiangyu Zhao

Blood (2025) 146 (Supplement 1): 2496.

https://doi.org/10.1182/blood-2025-2496

Published: 2025

Journal Articles

Development and prospective validation of a prognostic model for diffuse alveolar hemorrhage after allogeneic hematopoietic stem cell transplantation

Qiu-Sha Huang, Zhuo-Yu An, Peng Zhao, Xiaolu Zhu, Yun He, Hai-Xia Fu, Fengrong Wang, Yuanyuan Zhang, Xiao-Dong Mo, Wei Han, Chen-hua Yan, Ting-ting Han, Yao Chen, Yu Wang, Ying-Jun Chang, Xiang-Yu Zhao, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 4276.

https://doi.org/10.1182/blood-2025-4276

Published: 2025

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

All-trans retinoic acid for refractory cancer therapy-induced thrombocytopenia: A new option beyond TPO-ras?

Iguratimod plus low-dose rituximab as second-line treatment in adults with primary immune thrombocytopenia: A multicenter, open-label, randomized, controlled, Phase 2 trial

Clinical features and prognostic model for adenovirus infection following allogeneic hematopoietic stem cell transplantation: Insights from a Chinese cohort

The selective JAK1 inhibitor upadacitinib restores impaired neutrophil chemotaxis in the proplatelet formation of immune thrombocytopenia

A novel thiotepa-containing conditioning regimen for haploidentical hematopoietic cell transplantation in pediatric aplastic anemia at high risk of cardiotoxicity

Fus::ERG fusion represents adverse-plus risk group in AML patients: Evidence from a registry-based matched cohort Study

A novel Janus kinase 1 and 2 inhibitor, baricitinib, for steroid-refractory chronic graft-versus-host disease after allogeneic stem cell transplantation

IDH1/2 mutations predict a distinct high-risk subset in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia

Beyond the unknown: Leveraging machine learning to predict adverse outcomes in pregnant women with aplastic anemia from a representative nationwide cohort

Bzip in-frame mutations might abrogate the adverse prognosis of therapy-related CEBPA-mutated AML

Selecting the optimal bridging therapy for B-ALL: A multicenter comparison of blinatumomab, inotuzumab ozogamicin, and CAR-T prior to allo-HSCT

Low dose of IL-2 application for graft-versus-host disease prophylaxis following haploidentical stem cell transplantation

Ectopic EBV infection in T cells following allogeneic hematopoietic stem cell transplantation: Clinical outcomes and immunological characterization

Single-cell dissection of pathogenic T-cell response to tacrolimus in immune thrombocytopenia

Avatrombopag improves platelet engraftment after haploidentical hematopoietic stem cell transplantation: A randomized, double-blind, multicenter, placebo-controlled trial

Co-mutation of BCOR and BCORL1 was associated with favorable outcome in the adverse risk patients with Acute Myeloid Leukemia

Outcomes and risk factors of second allogeneic hematopoietic stem cell transplantation in patients with relapsed hematological malignancy after first transplantation

Droplet digital PCR improves measurable residual disease detection and predicts relapse in KMT2A-rearranged leukemia after allogeneic hematopoietic stem cell transplantation: A prospective study

Impact of HLA-b leader matching status on prognosis and underlying mechanism in patients with hematological malignancies following haploidentical hematopoietic stem cell transplantation

Development and prospective validation of a prognostic model for diffuse alveolar hemorrhage after allogeneic hematopoietic stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only